SCHEMBL4437450

SCHEMBL4437450

O=C(O)N1Cc2ccc(Br)cc2C1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABHD6 Q9BV23 3/20 0.55
DPP8 Q6V1X1 1/20 0.52
DPP9 Q86TI2 1/20 0.52
DPP7 Q9UHL4 1/20 0.52
HSP90AA1 P07900 1/20 0.47
NAMPT P43490 2/20 0.47
HSD17B3 P37058 4/20 0.45
SRD5A1 P18405 1/20 0.42
SRD5A2 P31213 1/20 0.42
AKR1C3 P42330 2/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
L3MBTL3 Q96JM7 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
TAS1R2 Q8TE23 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
NOTUM Q6P988 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1956852 1.00 ABHD6 (0.55) ABHD6DPP8DPP9DPP7HSP90AA1
SCHEMBL587507 0.86 ABHD6 (0.59) ABHD6DPP8DPP9DPP7HSD17B3
SCHEMBL3808915 0.86 ABHD6 (0.59) ABHD6DPP8DPP9DPP7HSD17B3
SCHEMBL31598007 0.86 ABHD6 (0.59) ABHD6DPP8DPP9DPP7HSD17B3
SCHEMBL29040812 0.83 ABHD6 (0.50) ABHD6DPP8DPP9DPP7NAMPT
SCHEMBL1263462 0.83 ABHD6 (0.50) ABHD6DPP8DPP9DPP7NAMPT
SCHEMBL16101941 0.83 NOTUM (0.60) ABHD6DPP8DPP9DPP7HSP90AA1
SCHEMBL21591709 0.81 ABHD6 (0.40) ABHD6DPP8DPP9DPP7HSP90AA1
SCHEMBL29104006 0.81 SRD5A1 (0.44) ABHD6DPP8DPP9DPP7HSP90AA1
SCHEMBL30575059 0.80 DPP8 (0.56) ABHD6DPP8DPP9DPP7HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125757-A1 MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS Novartis AG (CH) 2009-12-02 EP disclosed
EP-2125778-A1 CERTAIN PYRAZOLINE DERIVATIVES WITH KINASE INHIBITORY ACTIVITY Millennium Pharmaceuticals, Inc. (US) 2009-12-02 EP disclosed
WO-2008101665-A1 MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS NOVARTIS AG (CH) 2008-08-28 WO disclosed
WO-2008079277-A1 CERTAIN PYRAZOLINE DERIVATIVES WITH KINASE INHIBITORY ACTIVITY MILLENNIUM PHARMACEUTICALS, INC. (US) 2008-07-03 WO disclosed